Has Mark Thompson, DO received payments from drug or device companies?

Yes. Drug and device makers reported $15,074 in general payments to Mark Thompson, DO across 769 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Thompson, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Thompson, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Thompson, DO

Therapeutic Radiology · Lake City, FLNPI 1487646030

Payments from drug & device makers

$15,074in general payments, 2019–2025

Across 769 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Merck$975
Novartis$892
Seagen Inc.$747
E.r. Squibb & Sons, L.L.C.$681
Pfizer$647
plus $10K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	56	$1,184
Merck	50	$975
Novartis	56	$892
Seagen Inc.	37	$747
E.r. Squibb & Sons, L.L.C.	40	$681
Pfizer	34	$647
Amgen(2 entities)	31	$554
Johnson & Johnson(2 entities)	33	$554
Eisai Inc.	25	$498
Incyte Corporation	27	$496
Bayer	28	$492
Astellas Pharma US Inc	22	$479
Lilly USA, LLC	20	$387
Bristol Myers Squibb	20	$378
Myriad Genetic Laboratories, Inc.	17	$373
Daiichi Sankyo Inc.	18	$364
Takeda Pharmaceuticals U.S.A., Inc.	15	$352
Sanofi	18	$322
GSK	15	$280
Octapharma USA, Inc.	8	$277
Exelixis Inc.	13	$247
Servier Pharmaceuticals LLC	12	$221
Regeneron Healthcare Solutions, Inc.	11	$219
Dendreon Pharmaceuticals LLC	5	$208
EMD Serono, Inc.	8	$207
AbbVie	12	$200
Siemens Medical Solutions USA, Inc.	3	$193
Genentech USA, Inc.	9	$167
Ipsen Biopharmaceuticals, Inc	8	$150
Rigel Pharmaceuticals, Inc.	3	$127
Blue Earth Diagnostics	5	$118
Integra Lifesciences Corporation	1	$112
Pharmacyclics LLC, An Abbvie Company	7	$105
Stemline Therapeutics Inc.	4	$96
Blueprint Medicines Corporation	5	$91
G1 Therapeutics, Inc.	5	$85
Taiho Oncology, Inc.	4	$85
Boehringer Ingelheim	4	$84
Sun Pharmaceutical Industries Inc.	4	$72
Dova Pharmaceuticals	4	$64
Sumitomo Pharma America, Inc.	4	$64
AVEO Pharmaceuticals, Inc.	2	$64
Beigene USA, Inc.	2	$63
Puma Biotechnology, Inc.	4	$61
Sobi, Inc	2	$61
Adaptive Biotechnologies Corporation	4	$59
Pharmacosmos Therapeutics Inc.	3	$58
Tesaro, Inc.	3	$56
Array Biopharma Inc	3	$54
Teva Pharmaceuticals USA, Inc.	4	$52
Verity Pharmaceuticals Inc.	3	$50
Jazz Pharmaceuticals Inc.	3	$48
Elekta, Inc.	1	$44
Global Blood Therapeutics, Inc.	3	$42
Agios Pharmaceuticals, Inc.	2	$40
Aurobindo Pharma USA, Inc.	3	$40
Reflexion Medical, Inc.	1	$38
Pharmaessentia USA Corporation	2	$35
Myovant Sciences Inc.	2	$29
Helsinn Therapeutics (U.S.), Inc.	2	$25

How this compares

Too few therapeutic radiology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$1,580,006

Medicare patients

266

Services billed

7,987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other therapeutic radiology in Lake City

Constantine MantzCape Coral$156K
Steven StokesPanama City$18K
Kunal SaigalSarasota$17K
Luis CarrascosaOcala$8K
Bao Tran DoanAtlantis$4K
Arthur MatzkowitzTrinity$4K
Perry JohnsonMiami$3K
Sonal SuraBonita Springs$3K
Inder BhutianiWinter Haven$549
Steven MartinAtlantis$317

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →